Updates are available Correction dated 2021-12-08
Click to view Correction: https://doi.org/10.1038/s41467-021-27519-7
-
Authors
Postema, Merel C. https://orcid.org/0000-0002-1536-7062
van Rooij, Daan
Anagnostou, Evdokia
Arango, Celso
Auzias, Guillaume https://orcid.org/0000-0002-0414-5691
Behrmann, Marlene
Filho, Geraldo Busatto
Calderoni, Sara
Calvo, Rosa
Daly, Eileen
Deruelle, Christine
Di Martino, Adriana
Dinstein, Ilan https://orcid.org/0000-0001-8106-5209
Duran, Fabio Luis S. https://orcid.org/0000-0002-7603-6152
Durston, Sarah
Ecker, Christine
Ehrlich, Stefan
Fair, Damien https://orcid.org/0000-0001-8602-393X
Fedor, Jennifer
Feng, Xin
Fitzgerald, Jackie
Floris, Dorothea L.
Freitag, Christine M. https://orcid.org/0000-0001-9676-4782
Gallagher, Louise
Glahn, David C.
Gori, Ilaria
Haar, Shlomi https://orcid.org/0000-0003-2213-6585
Hoekstra, Liesbeth
Jahanshad, Neda https://orcid.org/0000-0003-4401-8950
Jalbrzikowski, Maria
Janssen, Joost
King, Joseph A. https://orcid.org/0000-0002-2864-5578
Kong, Xiang Zhen
Lazaro, Luisa
Lerch, Jason P.
Luna, Beatriz
Martinho, Mauricio M.
McGrath, Jane
Medland, Sarah E.
Muratori, Filippo
Murphy, Clodagh M. https://orcid.org/0000-0002-6350-0155
Murphy, Declan G. M. https://orcid.org/0000-0002-6664-7451
O’Hearn, Kirsten
Oranje, Bob
Parellada, Mara
Puig, Olga https://orcid.org/0000-0002-0533-5542
Retico, Alessandra https://orcid.org/0000-0001-5135-4472
Rosa, Pedro
Rubia, Katya
Shook, Devon
Taylor, Margot J.
Tosetti, Michela https://orcid.org/0000-0002-2515-7560
Wallace, Gregory L.
Zhou, Fengfeng https://orcid.org/0000-0002-8108-6007
Thompson, Paul M.
Fisher, Simon E. https://orcid.org/0000-0002-3132-1996
Buitelaar, Jan K. https://orcid.org/0000-0001-8288-7757
Francks, Clyde
- License Information
-
More Information
Article History
Received: 22 March 2019
Accepted: 1 October 2019
First Online: 31 October 2019
Change Date: 8 December 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-021-27519-7
Competing interests
: Dr. Anagnostou has served as a consultant or advisory board member for Roche and Takeda; she has received funding from the Alva Foundation, Autism Speaks, Brain Canada, the Canadian Institutes of Health Research, the Department of Defense, the National Centers of Excellence, NIH, the Ontario Brain Institute, the Physicians’ Services Incorporated (PSI) Foundation, Sanofi-Aventis, and SynapDx, as well as in-kind research support from AMO Pharma; she receives royalties from American Psychiatric Press and Springer and an editorial honorarium from Wiley. Her contribution is on behalf of the POND network. Dr. Arango has served as a consultant for or received honoraria or grants from Acadia, Abbott, Amgen, CIBERSAM, Fundación Alicia Koplowitz, Instituto de Salud Carlos III, Janssen-Cilag, Lundbeck, Merck, Instituto de Salud Carlos III (co-financed by the European Regional Development Fund “A way of making Europe,” CIBERSAM, the Madrid Regional Government [S2010/BMD-2422 AGES], the European Union Structural Funds, and the European Union Seventh Framework Programmeunder grant agreements FP7-HEALTH-2009-2.2.1-2-241909, FP7-HEALTH-2009-2.2.1-3-242114, FP7-HEALTH-2013-2.2.1-2-603196, and FP7-HEALTH-2013-2.2.1-2-602478), Otsuka, Pfizer, Roche, Servier, Shire, Takeda, and Schering-Plough. Dr. Freitag has served as a consultant for Desitin regarding issues on ASD. Dr. Di Martino is a coauthor of the Italian version of the Social Responsiveness Scale, for which she may receive royalties. Her contribution is on behalf of the ABIDE and ABIDEII consortia. Dr. Rubia has received speaking honoraria from Eli Lilly, Medice, and Shire, and a grant from Shire for another project. Dr. Thompson received partial research support from Biogen, Inc. (Boston), for research unrelated to the topic of this manuscript. Dr. Buitelaar has served as a consultant, advisory board member, or speaker for Eli Lilly, Janssen-Cilag, Lundbeck, Medice, Novartis, Servier, Shire, and Roche, and he has received research support from Roche and Vifor. The remaining authors declare no competing interests.
